Neurodiversity
& Substance Use

Editorial & evidence policy

About this Resource

This free UK educational resource is written by Tony D’Agostino, Director of TD Consultancy, drawing on extensive experience in drug and alcohol training, workforce development and evidence-informed practice. Its purpose is to make complex guidance usable without replacing individual clinical assessment.

Evidence reviewed 2 August 2026 · UK focus
01

Editorial approach

Content uses a compassionate, function-first approach. Established clinical or legal guidance, research findings, practical formulation and author commentary should be distinguished rather than blended together.

02

Evidence policy

Priority is given to reputable UK sources including NHS, NICE, GOV.UK, OHID and ONS alongside relevant peer-reviewed research. The 2026 publication reports evidence checked to 2 August 2026. Web pages display a review date and should be updated when material guidance changes.

03

Scope and limitations

This website is educational. It does not diagnose neurodevelopmental conditions, provide an individual treatment plan, replace detoxification advice, clinical assessment, safeguarding procedures or emergency care.

04

Corrections and updates

Accuracy is taken seriously. If you spot an error or an important update, contact TD Consultancy through the main website.

Evidence and scope

This page is educational and does not diagnose, replace individual clinical assessment, treatment, detoxification advice, safeguarding procedures or emergency care. Content is grounded in the 2026 publication and prioritises UK guidance and reputable evidence sources. See the editorial and evidence policy for scope and updates.

Read the editorial & evidence policy